-transparent.png){kind=logo}
Six serinal derivatives were synthesized and tested for their anti-human immunodeficiency virus type-1 (HIV-1) activity against HIV-1-infected cells. Of the 6 serinal derivatives tested, only N,O-didecanoyl serinal dimethylacetal (DDSD) was found to strongly suppress progeny virus production from acute HIV-1-infected CEM cells, while not suppressing the HIV-1 p24 production from latent HIV-1-infected ACH-2 cells after stimulation with phorbol 12-myristate 13-acetate. DDSD also inhibited the synthesis of HIV-1 proviral DNA at 20-50 microM, not only 1 h but also 24 h after HIV-1 infection. Taken together, DDSD is a potent inhibitor of HIV-1 production, and may become a unique leading compound for chemotherapy of acquired immunodeficiency syndrome.
N Takamune, and
S Misumi, and
K Furuishi, and
S Shoji
February 1989,
Biochemical and biophysical research communications,
N Takamune, and
S Misumi, and
K Furuishi, and
S Shoji
July 1969,
Arzneimittel-Forschung,
N Takamune, and
S Misumi, and
K Furuishi, and
S Shoji
November 2016,
The Journal of organic chemistry,
N Takamune, and
S Misumi, and
K Furuishi, and
S Shoji
January 1999,
Methods in molecular medicine,
N Takamune, and
S Misumi, and
K Furuishi, and
S Shoji
December 1993,
Rinsho byori. The Japanese journal of clinical pathology,
N Takamune, and
S Misumi, and
K Furuishi, and
S Shoji
August 1997,
Biochemical and biophysical research communications,
N Takamune, and
S Misumi, and
K Furuishi, and
S Shoji
January 2012,
PloS one,
N Takamune, and
S Misumi, and
K Furuishi, and
S Shoji
December 1994,
AIDS (London, England),
N Takamune, and
S Misumi, and
K Furuishi, and
S Shoji
October 2010,
The new microbiologica,
N Takamune, and
S Misumi, and
K Furuishi, and
S Shoji
June 2007,
Science (New York, N.Y.),
